Cargando…
063 Autoimmunity and disease outcomes of COVID-19, lessons from vitiligo patients
Autores principales: | Post, N., Bekkenk, M., Luiten, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672432/ http://dx.doi.org/10.1016/j.jid.2022.09.072 |
Ejemplares similares
-
Patients’ perspective on current treatments and demand for novel treatments in vitiligo
por: Narayan, V.S., et al.
Publicado: (2020) -
Targeting the PD-1/PD-L1 Axis in Human Vitiligo
por: Willemsen, Marcella, et al.
Publicado: (2020) -
Ultraviolet photography in vitiligo: image quality, validity and reliability
por: Uitentuis, S.E., et al.
Publicado: (2020) -
The use of lasers in vitiligo, an overview
por: Post, N.F., et al.
Publicado: (2022) -
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review
por: Narayan, V.S., et al.
Publicado: (2021)